These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 29353121)

  • 21. Tracking the development of agrammatic aphasia: A tensor-based morphometry study.
    Whitwell JL; Duffy JR; Machulda MM; Clark HM; Strand EA; Senjem ML; Gunter JL; Spychalla AJ; Petersen RC; Jack CR; Josephs KA
    Cortex; 2017 May; 90():138-148. PubMed ID: 27771043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
    Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE
    JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies.
    Kantarci K; Lowe VJ; Boeve BF; Senjem ML; Tosakulwong N; Lesnick TG; Spychalla AJ; Gunter JL; Fields JA; Graff-Radford J; Ferman TJ; Jones DT; Murray ME; Knopman DS; Jack CR; Petersen RC
    Ann Neurol; 2017 Jan; 81(1):58-67. PubMed ID: 27863444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal structural and molecular neuroimaging in agrammatic primary progressive aphasia.
    Tetzloff KA; Duffy JR; Clark HM; Strand EA; Machulda MM; Schwarz CG; Senjem ML; Reid RI; Spychalla AJ; Tosakulwong N; Lowe VJ; Jack CR; Josephs KA; Whitwell JL
    Brain; 2018 Jan; 141(1):302-317. PubMed ID: 29228180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [
    Whitwell JL; Lowe VJ; Tosakulwong N; Weigand SD; Senjem ML; Schwarz CG; Spychalla AJ; Petersen RC; Jack CR; Josephs KA
    Mov Disord; 2017 Jan; 32(1):124-133. PubMed ID: 27787958
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Tsai RM; Bejanin A; Lesman-Segev O; LaJoie R; Visani A; Bourakova V; O'Neil JP; Janabi M; Baker S; Lee SE; Perry DC; Bajorek L; Karydas A; Spina S; Grinberg LT; Seeley WW; Ramos EM; Coppola G; Gorno-Tempini ML; Miller BL; Rosen HJ; Jagust W; Boxer AL; Rabinovici GD
    Alzheimers Res Ther; 2019 Jan; 11(1):13. PubMed ID: 30704514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progressive apraxia of speech in Quebec French speakers: A case series.
    Bouvier L; Monetta L; Laforce RJ; Vitali P; Bocti C; Martel-Sauvageau V
    Int J Lang Commun Disord; 2021 May; 56(3):528-548. PubMed ID: 33570823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amyloid and tau PET demonstrate region-specific associations in normal older people.
    Lockhart SN; Schöll M; Baker SL; Ayakta N; Swinnerton KN; Bell RK; Mellinger TJ; Shah VD; O'Neil JP; Janabi M; Jagust WJ
    Neuroimage; 2017 Apr; 150():191-199. PubMed ID: 28232190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals.
    Tosun D; Landau S; Aisen PS; Petersen RC; Mintun M; Jagust W; Weiner MW;
    Brain; 2017 May; 140(5):1499-1512. PubMed ID: 28334939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease.
    Xia C; Makaretz SJ; Caso C; McGinnis S; Gomperts SN; Sepulcre J; Gomez-Isla T; Hyman BT; Schultz A; Vasdev N; Johnson KA; Dickerson BC
    JAMA Neurol; 2017 Apr; 74(4):427-436. PubMed ID: 28241163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of β-amyloid on [
    Whitwell JL; Martin PR; Duffy JR; Clark HM; Machulda MM; Schwarz CG; Weigand SD; Sintini I; Senjem ML; Ertekin-Taner N; Botha H; Utianski RL; Graff-Radford J; Jones DT; Boeve BF; Knopman DS; Petersen RC; Jack CR; Lowe VJ; Josephs KA
    Neurology; 2019 Feb; 92(7):e710-e722. PubMed ID: 30635491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech.
    Josephs KA; Duffy JR; Strand EA; Whitwell JL; Layton KF; Parisi JE; Hauser MF; Witte RJ; Boeve BF; Knopman DS; Dickson DW; Jack CR; Petersen RC
    Brain; 2006 Jun; 129(Pt 6):1385-98. PubMed ID: 16613895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. APOE ε4 influences β-amyloid deposition in primary progressive aphasia and speech apraxia.
    Josephs KA; Duffy JR; Strand EA; Machulda MM; Senjem ML; Lowe VJ; Jack CR; Whitwell JL
    Alzheimers Dement; 2014 Nov; 10(6):630-6. PubMed ID: 24985533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study.
    Seckin ZI; Duffy JR; Strand EA; Clark HM; Utianski RL; Machulda MM; Botha H; Ali F; Thu Pham NT; Lowe VJ; Whitwell JL; Josephs KA
    Parkinsonism Relat Disord; 2020 Dec; 81():34-40. PubMed ID: 33045651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-word comprehension deficits in the nonfluent variant of primary progressive aphasia.
    Schaeverbeke J; Gabel S; Meersmans K; Bruffaerts R; Liuzzi AG; Evenepoel C; Dries E; Van Bouwel K; Sieben A; Pijnenburg Y; Peeters R; Bormans G; Van Laere K; Koole M; Dupont P; Vandenberghe R
    Alzheimers Res Ther; 2018 Jul; 10(1):68. PubMed ID: 30021613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET study.
    Holland N; Malpetti M; Rittman T; Mak EE; Passamonti L; Kaalund SS; Hezemans FH; Jones PS; Savulich G; Hong YT; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
    Brain; 2022 Mar; 145(1):340-348. PubMed ID: 34398211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progressive agrammatic aphasia without apraxia of speech as a distinct syndrome.
    Tetzloff KA; Duffy JR; Clark HM; Utianski RL; Strand EA; Machulda MM; Botha H; Martin PR; Schwarz CG; Senjem ML; Reid RI; Gunter JL; Spychalla AJ; Knopman DS; Petersen RC; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
    Brain; 2019 Aug; 142(8):2466-2482. PubMed ID: 31199471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progression to corticobasal syndrome: a longitudinal study of patients with nonfluent primary progressive aphasia and primary progressive apraxia of speech.
    Garcia-Guaqueta DP; Botha H; Utianski RL; Duffy JR; Clark HM; Goodrich AW; Pham NTT; Machulda MM; Baker M; Rademakers R; Whitwell JL; Josephs KA
    J Neurol; 2024 Jul; 271(7):4168-4179. PubMed ID: 38583104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative Analysis of Agrammatism in Agrammatic Primary Progressive Aphasia and Dominant Apraxia of Speech.
    Tetzloff KA; Utianski RL; Duffy JR; Clark HM; Strand EA; Josephs KA; Whitwell JL
    J Speech Lang Hear Res; 2018 Sep; 61(9):2337-2346. PubMed ID: 30098169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.